Have a personal or library account? Click to login
Anxiety disorders as the most common mental illnesses – diagnostic and treatment methods Cover

Anxiety disorders as the most common mental illnesses – diagnostic and treatment methods

Open Access
|Jun 2025

References

  1. Ströhle A, Gensichen J, Domschke K. The Diagnosis and Treatment of Anxiety Disorders. Dtsch Arztebl Int. 2018;155(37):611-620. doi:10.3238/arztebl.2018.0611
  2. DeGeorge KC, Grover M, Streeter GS. Generalized Anxiety Disorder and Panic Disorder in Adults. Am Fam Physician. 2022;106(2):157-164.
  3. Schiele MA, Domschke K. Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders. Genes Brain Behav. 2018;17(3):e12423. doi:10.1111/gbb.12423
  4. Paulesu E, Sambugaro E, Torti T, et al. Neural correlates of worry in generalized anxiety disorder and in normal controls: a functional MRI study. Psychol Med. 2010;40(1):117-124. doi:10.1017/S0033291709005649
  5. Yang X, Fang Y, Chen H, et al. Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019. Epidemiol Psychiatr Sci. 2021;30:e36. doi:10.1017/S2045796021000275
  6. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655-679. doi:10.1016/j.euroneuro.2011.07.018
  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013. doi:10.1176/appi.books.9780890425596
  8. World Health Organization. Mental Disorders. Accessed March 23, 2025. https://www.who.int/news-room/fact-sheets/detail/mental-disorders
  9. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327-335. doi:10.31887/DCNS.2015.17.3/bbandelow
  10. Stein D, Vythilingum B. Anxiety Disorder and Gender. (Domschke K, Bendelow B, eds.). Springer; 2015.
  11. Wolitzky-Taylor KB, Castriotta N, Lenze EJ, Stanley MA, Craske MG. Anxiety disorders in older adults: a comprehensive review. Depress Anxiety. 2010;27(2):190-211. doi:10.1002/da.20653
  12. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259. doi:10.1016/S0140-6736(17)32154-2
  13. Baldwin DS, Allgulander C, Bandelow B, Ferre F, Pallanti S. An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder. World J Biol Psychiatry. 2012;13(7):510-516. doi:10.3109/15622975.2011.624548
  14. Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015;91(9):617-624.
  15. Anxiety and Depression Association of America. GAD-7 Anxiety. Accessed March 23, 2025. https://adaa.org/sites/default/files/GAD-7_Anxiety-updated_0.pdf
  16. Penninx BW, Pine DS, Holmes EA, Reif A. Anxiety disorders. Lancet. 2021;397(10277):914-927. doi:10.1016/S0140-6736(21)00359-7
  17. Van Apeldoorn FJ, Van Hout WJPJ, Timmerman ME, Mersch PPA, Den Boer JA. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: Cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined. J Affect Disord. 2013;150(2):313-319. doi:10.1016/J.JAD.2013.04.012
  18. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology. 2014;28(5):403-439. doi:10.1177/0269881114525674
  19. Bandelow B, Boerner J R, Kasper S, Linden M, Wittchen HU, Möller HJ. The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int. 2013;110(17):300-309; quiz 310. doi:10.3238/arztebl.2013.0300
  20. Fagan HA, Baldwin DS. Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions. Expert Rev Neurother. 2023;23(6):535-548. doi:10.1080/14737175.2023.2211767
  21. Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. Pharmacotherapy. 2023;43(7):675-690. doi:10.1002/phar.2767
  22. Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 2014;77(2):295-301. doi:10.1111/j.1365-2125.2012.04418.x
  23. Hoge EA, Ivkovic A, Fricchione GL. Generalized anxiety disorder: diagnosis and treatment. BMJ. 2012;345:e7500. doi:10.1136/bmj.e7500
  24. Shearer SL. Recent Advances in the Understanding and Treatment of Anxiety Disorders. Primary Care: Clinics in Office Practice. 2007;34(3):475-504. doi:10.1016/J.POP.2007.05.002
  25. Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015;91(9):617-624.
  26. Smits JAJ, Berry AC, Rosenfield D, Powers MB, Behar E, Otto MW. Reducing anxiety sensitivity with exercise. Depress Anxiety. 2008;25(8):689-699. doi:10.1002/da.20411
  27. National Institute for Health and Care Excellence. Generalised Anxiety Disorder and Panic Disorder in Adults: Management in Primary, Secondary and Community Care.; 2011.
  28. Borza L. Cognitive-behavioral therapy for generalized anxiety. Dialogues Clin Neurosci. 2017;19(2):203-208. doi:10.31887/DCNS.2017.19.2/lborza
  29. Khoury B, Lecomte T, Fortin G, et al. Mindfulness-based therapy: A comprehensive meta-analysis. Clin Psychol Rev. 2013;33(6):763-771. doi:10.1016/J.CPR.2013.05.005
  30. Ribeiro Â, Ribeiro JP, von Doellinger O. Depression and psychodynamic psychotherapy. Braz J Psychiatry. 2018;40(1):105-109. doi:10.1590/1516-4446-2016-2107
  31. Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry. 2014;13(1):56-67. doi:10.1002/wps.20089
DOI: https://doi.org/10.2478/bgbl-2025-0005 | Journal eISSN: 2956-6851 | Journal ISSN: 0373-174X
Language: English
Page range: 49 - 59
Published on: Jun 12, 2025
Published by: The Medical Library named after S. Konopka in Warsaw
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2025 Gabriela Maria Piech, Igor Lis, Piotr Kurzyna, Christian S. Skowron, published by The Medical Library named after S. Konopka in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.